Amy Jacobs

817 total citations
29 papers, 625 citations indexed

About

Amy Jacobs is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Amy Jacobs has authored 29 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Virology and 10 papers in Molecular Biology. Recurrent topics in Amy Jacobs's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (14 papers) and RNA Interference and Gene Delivery (4 papers). Amy Jacobs is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (14 papers) and RNA Interference and Gene Delivery (4 papers). Amy Jacobs collaborates with scholars based in United States, Austria and Israel. Amy Jacobs's co-authors include Michael Caffrey, Hyun Yi, Robert Blumenthal, Robert C. Rizzo, Sriram Neelamegham, Shuai Shao, Jumin Geng, Jonathan F. Lovell, Lijun Rong and Gabriela Stiegler and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Virology.

In The Last Decade

Amy Jacobs

29 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Jacobs United States 14 292 286 213 155 131 29 625
Joshua S. Klein United States 11 312 1.1× 288 1.0× 113 0.5× 241 1.6× 259 2.0× 12 768
Sara M. O’Rourke United States 15 280 1.0× 210 0.7× 182 0.9× 172 1.1× 141 1.1× 37 579
Nathan I. Nicely United States 14 415 1.4× 330 1.2× 127 0.6× 273 1.8× 164 1.3× 25 807
Andrei N. Vzorov United States 16 186 0.6× 274 1.0× 152 0.7× 194 1.3× 53 0.4× 29 673
Neal N. Padte United States 13 213 0.7× 307 1.1× 219 1.0× 223 1.4× 154 1.2× 15 640
K. Strutzenberger Austria 7 266 0.9× 372 1.3× 139 0.7× 237 1.5× 213 1.6× 9 624
Torben Schiffner United States 13 176 0.6× 329 1.2× 123 0.6× 244 1.6× 107 0.8× 20 513
Chatchai Tayapiwatana Thailand 16 418 1.4× 127 0.4× 122 0.6× 105 0.7× 143 1.1× 87 705
Anupriya Aggarwal Australia 15 265 0.9× 175 0.6× 207 1.0× 134 0.9× 42 0.3× 31 678

Countries citing papers authored by Amy Jacobs

Since Specialization
Citations

This map shows the geographic impact of Amy Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Jacobs more than expected).

Fields of papers citing papers by Amy Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Jacobs. The network helps show where Amy Jacobs may publish in the future.

Co-authorship network of co-authors of Amy Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Jacobs. A scholar is included among the top collaborators of Amy Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Jacobs. Amy Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woodall, Maximillian, Samuel Ellis, Shengyuan Zhang, et al.. (2024). Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains. Antimicrobial Agents and Chemotherapy. 69(2). e0123324–e0123324. 1 indexed citations
2.
Riley, Sean P., et al.. (2023). Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals. Viruses. 15(3). 793–793. 2 indexed citations
3.
Humby, Monica S., et al.. (2019). Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry. Journal of Virology. 93(15). 12 indexed citations
4.
McGee, T. Dwight, Hyun Yi, William J. Allen, Amy Jacobs, & Robert C. Rizzo. (2017). Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer. Bioorganic & Medicinal Chemistry Letters. 27(14). 3177–3184. 10 indexed citations
5.
Yi, Hyun, Brian Fochtman, Robert C. Rizzo, & Amy Jacobs. (2016). Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41. Current HIV Research. 14(3). 283–294. 42 indexed citations
6.
Jacobs, Amy. (2016). Radiofrequency Ablation for Liver Cancer.. PubMed. 86(6). 645–64; quiz 665. 9 indexed citations
7.
Allen, William J., Hyun Yi, Miriam Gochin, Amy Jacobs, & Robert C. Rizzo. (2015). Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation. Bioorganic & Medicinal Chemistry Letters. 25(14). 2853–2859. 15 indexed citations
8.
Shao, Shuai, Jumin Geng, Hyun Yi, et al.. (2015). Functionalization of cobalt porphyrin–phospholipid bilayers with his-tagged ligands and antigens. Nature Chemistry. 7(5). 438–446. 124 indexed citations
9.
Rotem‐Bamberger, Shahar, Mathias Viard, Amy Jacobs, et al.. (2013). Mapping the Vif–A3G interaction using peptide arrays: A basis for anti-HIV lead peptides. Bioorganic & Medicinal Chemistry. 21(12). 3523–3532. 10 indexed citations
10.
Garg, Himanshu, Mathias Viard, Amy Jacobs, & Robert Blumenthal. (2011). Targeting HIV-1 gp41-induced Fusion and Pathogenesis for Anti-viral Therapy. Current Topics in Medicinal Chemistry. 11(24). 2947–2958. 13 indexed citations
11.
Yi, Hyun, John C. Panepinto, & Amy Jacobs. (2011). Inhibition of HIV entry by extracellular glucuronoxylomannan of Cryptococcus neoformans. Microbial Pathogenesis. 52(1). 25–30. 3 indexed citations
12.
Zieliński, Rafał, Ilya Lyakhov, Amy Jacobs, et al.. (2009). Affitoxin—A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors. Journal of Immunotherapy. 32(8). 817–825. 60 indexed citations
13.
Jacobs, Amy, Himanshu Garg, Mathias Viard, et al.. (2008). HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development. Vaccine. 26(24). 3026–3035. 17 indexed citations
14.
Jacobs, Amy, Omar Quraishi, Xicai Huang, et al.. (2007). A Covalent Inhibitor Targeting an Intermediate Conformation of the Fusogenic Subunit of the HIV-1 Envelope Complex. Journal of Biological Chemistry. 282(44). 32406–32413. 17 indexed citations
15.
Jacobs, Amy, et al.. (2007). The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160. Protein Science. 16(6). 1236–1241. 20 indexed citations
16.
Jacobs, Amy, et al.. (2006). Thermostability of the HIV gp41 Wild-Type and Loop Mutations. Protein and Peptide Letters. 13(5). 477–480. 9 indexed citations
17.
Jacobs, Amy, et al.. (2005). Alanine Scanning Mutants of the HIV gp41 Loop. Journal of Biological Chemistry. 280(29). 27284–27288. 42 indexed citations
18.
Jacobs, Amy, Kari L. Hartman, Thomas M. Laue, & Michael Caffrey. (2004). Sedimentation velocity studies of the high–molecular weight aggregates of the HIV gp41 ectodomain. Protein Science. 13(10). 2811–2813. 4 indexed citations
19.
Guilhaudis, Laure, Amy Jacobs, & Michael Caffrey. (2002). Solution structure of the HIV gp120 C5 Domain. European Journal of Biochemistry. 269(19). 4860–4867. 20 indexed citations
20.
Jacobs, Amy, et al.. (2001). Heparin binding by the HIV‐1 tat protein transduction domain. Protein Science. 10(10). 2138–2139. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joshua S. Klein Breakdown of academic impact, for papers by Sara M. O’Rourke Breakdown of academic impact, for papers by Nathan I. Nicely Breakdown of academic impact, for papers by Andrei N. Vzorov Breakdown of academic impact, for papers by Neal N. Padte Breakdown of academic impact, for papers by K. Strutzenberger Breakdown of academic impact, for papers by Torben Schiffner Breakdown of academic impact, for papers by Chatchai Tayapiwatana Breakdown of academic impact, for papers by Anupriya Aggarwal
Rankless by CCL
2026